nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.064	0.116	CbGbCtD
Regorafenib—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.0523	0.0946	CbGbCtD
Regorafenib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0466	0.0842	CbGbCtD
Regorafenib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0288	0.052	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0231	0.0418	CbGbCtD
Regorafenib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0218	0.0394	CbGbCtD
Regorafenib—CYP2C8—Dapsone—systemic lupus erythematosus	0.0177	0.032	CbGbCtD
Regorafenib—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0173	0.0313	CbGbCtD
Regorafenib—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0153	0.0277	CbGbCtD
Regorafenib—CYP2C19—Dapsone—systemic lupus erythematosus	0.0148	0.0268	CbGbCtD
Regorafenib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0144	0.026	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0137	0.0248	CbGbCtD
Regorafenib—CYP2C9—Dapsone—systemic lupus erythematosus	0.0123	0.0223	CbGbCtD
Regorafenib—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0123	0.0222	CbGbCtD
Regorafenib—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0116	0.021	CbGbCtD
Regorafenib—ABCG2—Methotrexate—systemic lupus erythematosus	0.0115	0.0209	CbGbCtD
Regorafenib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0104	0.0188	CbGbCtD
Regorafenib—CYP2C19—Prednisone—systemic lupus erythematosus	0.0103	0.0186	CbGbCtD
Regorafenib—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.0101	0.0183	CbGbCtD
Regorafenib—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00975	0.0176	CbGbCtD
Regorafenib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00891	0.0161	CbGbCtD
Regorafenib—ABCB1—Prednisolone—systemic lupus erythematosus	0.00879	0.0159	CbGbCtD
Regorafenib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00833	0.0151	CbGbCtD
Regorafenib—ABCB1—Prednisone—systemic lupus erythematosus	0.0083	0.015	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00821	0.0148	CbGbCtD
Regorafenib—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00811	0.0147	CbGbCtD
Regorafenib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00787	0.0142	CbGbCtD
Regorafenib—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00765	0.0138	CbGbCtD
Regorafenib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00717	0.013	CbGbCtD
Regorafenib—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00642	0.0116	CbGbCtD
Regorafenib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00622	0.0112	CbGbCtD
Regorafenib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00622	0.0112	CbGbCtD
Regorafenib—CYP2C9—cardial valve—systemic lupus erythematosus	0.00539	0.0449	CbGeAlD
Regorafenib—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00534	0.00965	CbGbCtD
Regorafenib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00534	0.00964	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00527	0.00952	CbGbCtD
Regorafenib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00518	0.00936	CbGbCtD
Regorafenib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00499	0.00902	CbGbCtD
Regorafenib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00497	0.00899	CbGbCtD
Regorafenib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00471	0.00852	CbGbCtD
Regorafenib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00416	0.00752	CbGbCtD
Regorafenib—FLT1—umbilical vein—systemic lupus erythematosus	0.00383	0.0319	CbGeAlD
Regorafenib—KDR—umbilical vein—systemic lupus erythematosus	0.00324	0.027	CbGeAlD
Regorafenib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0031	0.00561	CbGbCtD
Regorafenib—UGT1A1—urine—systemic lupus erythematosus	0.00276	0.023	CbGeAlD
Regorafenib—FLT4—endothelium—systemic lupus erythematosus	0.00234	0.0195	CbGeAlD
Regorafenib—TEK—endothelium—systemic lupus erythematosus	0.00188	0.0157	CbGeAlD
Regorafenib—FLT1—endothelium—systemic lupus erythematosus	0.00182	0.0151	CbGeAlD
Regorafenib—DDR2—connective tissue—systemic lupus erythematosus	0.00181	0.0151	CbGeAlD
Regorafenib—DDR2—skin of body—systemic lupus erythematosus	0.00164	0.0136	CbGeAlD
Regorafenib—FLT1—blood plasma—systemic lupus erythematosus	0.00161	0.0134	CbGeAlD
Regorafenib—KDR—endothelium—systemic lupus erythematosus	0.00154	0.0128	CbGeAlD
Regorafenib—CYP2C19—urine—systemic lupus erythematosus	0.0015	0.0125	CbGeAlD
Regorafenib—FRK—lymphoid tissue—systemic lupus erythematosus	0.00148	0.0123	CbGeAlD
Regorafenib—UGT1A1—blood plasma—systemic lupus erythematosus	0.00144	0.012	CbGeAlD
Regorafenib—KDR—blood plasma—systemic lupus erythematosus	0.00136	0.0114	CbGeAlD
Regorafenib—KIT—endothelium—systemic lupus erythematosus	0.00136	0.0113	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—systemic lupus erythematosus	0.00133	0.0111	CbGeAlD
Regorafenib—DDR2—tendon—systemic lupus erythematosus	0.00125	0.0104	CbGeAlD
Regorafenib—KIT—blood plasma—systemic lupus erythematosus	0.00121	0.0101	CbGeAlD
Regorafenib—EPHX2—nephron tubule—systemic lupus erythematosus	0.00119	0.00989	CbGeAlD
Regorafenib—CYP2C9—urine—systemic lupus erythematosus	0.00116	0.00968	CbGeAlD
Regorafenib—DDR2—lung—systemic lupus erythematosus	0.00109	0.00912	CbGeAlD
Regorafenib—EPHX2—cortex of kidney—systemic lupus erythematosus	0.00102	0.00846	CbGeAlD
Regorafenib—DDR2—nervous system—systemic lupus erythematosus	0.00101	0.00844	CbGeAlD
Regorafenib—RET—connective tissue—systemic lupus erythematosus	0.000976	0.00813	CbGeAlD
Regorafenib—DDR2—central nervous system—systemic lupus erythematosus	0.000976	0.00813	CbGeAlD
Regorafenib—MAPK11—nervous system—systemic lupus erythematosus	0.000961	0.008	CbGeAlD
Regorafenib—UGT1A9—kidney—systemic lupus erythematosus	0.000954	0.00795	CbGeAlD
Regorafenib—FGFR2—connective tissue—systemic lupus erythematosus	0.000927	0.00772	CbGeAlD
Regorafenib—MAPK11—central nervous system—systemic lupus erythematosus	0.000925	0.00771	CbGeAlD
Regorafenib—FLT4—cortex of kidney—systemic lupus erythematosus	0.000916	0.00763	CbGeAlD
Regorafenib—FGFR1—cortex of kidney—systemic lupus erythematosus	0.000904	0.00753	CbGeAlD
Regorafenib—TEK—connective tissue—systemic lupus erythematosus	0.000889	0.0074	CbGeAlD
Regorafenib—CYP3A4—urine—systemic lupus erythematosus	0.000886	0.00738	CbGeAlD
Regorafenib—EPHA2—nephron tubule—systemic lupus erythematosus	0.000883	0.00735	CbGeAlD
Regorafenib—BRAF—tendon—systemic lupus erythematosus	0.000881	0.00734	CbGeAlD
Regorafenib—FLT1—connective tissue—systemic lupus erythematosus	0.000859	0.00716	CbGeAlD
Regorafenib—RAF1—connective tissue—systemic lupus erythematosus	0.000854	0.00712	CbGeAlD
Regorafenib—BRAF—bone marrow—systemic lupus erythematosus	0.000854	0.00711	CbGeAlD
Regorafenib—EPHX2—tendon—systemic lupus erythematosus	0.000842	0.00702	CbGeAlD
Regorafenib—FGFR2—skin of body—systemic lupus erythematosus	0.000837	0.00697	CbGeAlD
Regorafenib—FLT1—nephron tubule—systemic lupus erythematosus	0.000832	0.00693	CbGeAlD
Regorafenib—RET—kidney—systemic lupus erythematosus	0.000831	0.00692	CbGeAlD
Regorafenib—RAF1—nephron tubule—systemic lupus erythematosus	0.000828	0.00689	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—systemic lupus erythematosus	0.000808	0.00673	CbGeAlD
Regorafenib—PDGFRA—connective tissue—systemic lupus erythematosus	0.000805	0.00671	CbGeAlD
Regorafenib—FGFR2—kidney—systemic lupus erythematosus	0.000789	0.00657	CbGeAlD
Regorafenib—CYP2C19—blood plasma—systemic lupus erythematosus	0.000782	0.00652	CbGeAlD
Regorafenib—BRAF—lung—systemic lupus erythematosus	0.000773	0.00644	CbGeAlD
Regorafenib—RAF1—skin of body—systemic lupus erythematosus	0.000771	0.00643	CbGeAlD
Regorafenib—TEK—kidney—systemic lupus erythematosus	0.000757	0.0063	CbGeAlD
Regorafenib—FGFR1—tendon—systemic lupus erythematosus	0.000749	0.00624	CbGeAlD
Regorafenib—EPHX2—lung—systemic lupus erythematosus	0.000739	0.00616	CbGeAlD
Regorafenib—TEK—cortex of kidney—systemic lupus erythematosus	0.000737	0.00614	CbGeAlD
Regorafenib—FLT4—bone marrow—systemic lupus erythematosus	0.000736	0.00613	CbGeAlD
Regorafenib—FLT1—kidney—systemic lupus erythematosus	0.000732	0.00609	CbGeAlD
Regorafenib—RAF1—kidney—systemic lupus erythematosus	0.000727	0.00606	CbGeAlD
Regorafenib—KDR—connective tissue—systemic lupus erythematosus	0.000726	0.00605	CbGeAlD
Regorafenib—RET—lymphoid tissue—systemic lupus erythematosus	0.000713	0.00594	CbGeAlD
Regorafenib—FLT1—cortex of kidney—systemic lupus erythematosus	0.000712	0.00594	CbGeAlD
Regorafenib—RAF1—cortex of kidney—systemic lupus erythematosus	0.000708	0.0059	CbGeAlD
Regorafenib—KDR—nephron tubule—systemic lupus erythematosus	0.000704	0.00586	CbGeAlD
Regorafenib—CYP2C8—blood plasma—systemic lupus erythematosus	0.000683	0.00569	CbGeAlD
Regorafenib—RET—tendon—systemic lupus erythematosus	0.000671	0.00559	CbGeAlD
Regorafenib—FLT4—lung—systemic lupus erythematosus	0.000667	0.00555	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—systemic lupus erythematosus	0.000666	0.00555	CbGeAlD
Regorafenib—FGFR1—lung—systemic lupus erythematosus	0.000658	0.00548	CbGeAlD
Regorafenib—UGT1A1—kidney—systemic lupus erythematosus	0.000654	0.00545	CbGeAlD
Regorafenib—TEK—lymphoid tissue—systemic lupus erythematosus	0.00065	0.00541	CbGeAlD
Regorafenib—KIT—connective tissue—systemic lupus erythematosus	0.000644	0.00536	CbGeAlD
Regorafenib—PDGFRB—connective tissue—systemic lupus erythematosus	0.000629	0.00524	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—systemic lupus erythematosus	0.000628	0.00523	CbGeAlD
Regorafenib—EPHA2—tendon—systemic lupus erythematosus	0.000626	0.00522	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—systemic lupus erythematosus	0.000625	0.0052	CbGeAlD
Regorafenib—KIT—nephron tubule—systemic lupus erythematosus	0.000624	0.00519	CbGeAlD
Regorafenib—KDR—kidney—systemic lupus erythematosus	0.000618	0.00515	CbGeAlD
Regorafenib—CYP2B6—blood plasma—systemic lupus erythematosus	0.000612	0.0051	CbGeAlD
Regorafenib—TEK—tendon—systemic lupus erythematosus	0.000611	0.00509	CbGeAlD
Regorafenib—CYP2C9—blood plasma—systemic lupus erythematosus	0.000606	0.00505	CbGeAlD
Regorafenib—KDR—cortex of kidney—systemic lupus erythematosus	0.000602	0.00502	CbGeAlD
Regorafenib—FLT1—tendon—systemic lupus erythematosus	0.000591	0.00492	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—systemic lupus erythematosus	0.000589	0.0049	CbGeAlD
Regorafenib—RAF1—tendon—systemic lupus erythematosus	0.000587	0.00489	CbGeAlD
Regorafenib—KIT—skin of body—systemic lupus erythematosus	0.000581	0.00484	CbGeAlD
Regorafenib—RAF1—bone marrow—systemic lupus erythematosus	0.000569	0.00474	CbGeAlD
Regorafenib—PDGFRB—skin of body—systemic lupus erythematosus	0.000568	0.00473	CbGeAlD
Regorafenib—ABL1—connective tissue—systemic lupus erythematosus	0.00056	0.00467	CbGeAlD
Regorafenib—FGFR2—lung—systemic lupus erythematosus	0.000559	0.00466	CbGeAlD
Regorafenib—PDGFRA—tendon—systemic lupus erythematosus	0.000553	0.00461	CbGeAlD
Regorafenib—EPHA2—lung—systemic lupus erythematosus	0.00055	0.00458	CbGeAlD
Regorafenib—KIT—kidney—systemic lupus erythematosus	0.000548	0.00457	CbGeAlD
Regorafenib—RET—nervous system—systemic lupus erythematosus	0.000545	0.00454	CbGeAlD
Regorafenib—ABL1—nephron tubule—systemic lupus erythematosus	0.000543	0.00452	CbGeAlD
Regorafenib—TEK—lung—systemic lupus erythematosus	0.000536	0.00447	CbGeAlD
Regorafenib—PDGFRB—kidney—systemic lupus erythematosus	0.000535	0.00446	CbGeAlD
Regorafenib—KIT—cortex of kidney—systemic lupus erythematosus	0.000534	0.00445	CbGeAlD
Regorafenib—KDR—lymphoid tissue—systemic lupus erythematosus	0.000531	0.00442	CbGeAlD
Regorafenib—RET—central nervous system—systemic lupus erythematosus	0.000525	0.00437	CbGeAlD
Regorafenib—PDGFRB—cortex of kidney—systemic lupus erythematosus	0.000521	0.00434	CbGeAlD
Regorafenib—FLT1—lung—systemic lupus erythematosus	0.000518	0.00432	CbGeAlD
Regorafenib—FGFR2—nervous system—systemic lupus erythematosus	0.000518	0.00431	CbGeAlD
Regorafenib—RAF1—lung—systemic lupus erythematosus	0.000515	0.00429	CbGeAlD
Regorafenib—EPHA2—nervous system—systemic lupus erythematosus	0.000509	0.00424	CbGeAlD
Regorafenib—ABL1—skin of body—systemic lupus erythematosus	0.000506	0.00422	CbGeAlD
Regorafenib—KDR—tendon—systemic lupus erythematosus	0.000499	0.00416	CbGeAlD
Regorafenib—FGFR2—central nervous system—systemic lupus erythematosus	0.000499	0.00415	CbGeAlD
Regorafenib—TEK—nervous system—systemic lupus erythematosus	0.000496	0.00414	CbGeAlD
Regorafenib—EPHA2—central nervous system—systemic lupus erythematosus	0.00049	0.00408	CbGeAlD
Regorafenib—PDGFRA—lung—systemic lupus erythematosus	0.000486	0.00405	CbGeAlD
Regorafenib—KDR—bone marrow—systemic lupus erythematosus	0.000484	0.00403	CbGeAlD
Regorafenib—FLT1—nervous system—systemic lupus erythematosus	0.00048	0.004	CbGeAlD
Regorafenib—TEK—central nervous system—systemic lupus erythematosus	0.000478	0.00398	CbGeAlD
Regorafenib—RAF1—nervous system—systemic lupus erythematosus	0.000477	0.00398	CbGeAlD
Regorafenib—ABL1—kidney—systemic lupus erythematosus	0.000477	0.00397	CbGeAlD
Regorafenib—KIT—lymphoid tissue—systemic lupus erythematosus	0.000471	0.00392	CbGeAlD
Regorafenib—ABL1—cortex of kidney—systemic lupus erythematosus	0.000465	0.00387	CbGeAlD
Regorafenib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000462	0.00385	CbGeAlD
Regorafenib—FLT1—central nervous system—systemic lupus erythematosus	0.000462	0.00385	CbGeAlD
Regorafenib—PDGFRB—lymphoid tissue—systemic lupus erythematosus	0.00046	0.00383	CbGeAlD
Regorafenib—RAF1—central nervous system—systemic lupus erythematosus	0.000459	0.00383	CbGeAlD
Regorafenib—PDGFRA—nervous system—systemic lupus erythematosus	0.00045	0.00375	CbGeAlD
Regorafenib—KDR—lung—systemic lupus erythematosus	0.000438	0.00365	CbGeAlD
Regorafenib—PDGFRA—central nervous system—systemic lupus erythematosus	0.000433	0.00361	CbGeAlD
Regorafenib—PDGFRB—tendon—systemic lupus erythematosus	0.000432	0.0036	CbGeAlD
Regorafenib—KIT—bone marrow—systemic lupus erythematosus	0.000429	0.00357	CbGeAlD
Regorafenib—PDGFRB—bone marrow—systemic lupus erythematosus	0.000419	0.00349	CbGeAlD
Regorafenib—ABL1—lymphoid tissue—systemic lupus erythematosus	0.00041	0.00341	CbGeAlD
Regorafenib—KDR—nervous system—systemic lupus erythematosus	0.000406	0.00338	CbGeAlD
Regorafenib—KDR—central nervous system—systemic lupus erythematosus	0.000391	0.00325	CbGeAlD
Regorafenib—KIT—lung—systemic lupus erythematosus	0.000388	0.00323	CbGeAlD
Regorafenib—ABL1—tendon—systemic lupus erythematosus	0.000385	0.00321	CbGeAlD
Regorafenib—PDGFRB—lung—systemic lupus erythematosus	0.000379	0.00316	CbGeAlD
Regorafenib—ABL1—bone marrow—systemic lupus erythematosus	0.000373	0.00311	CbGeAlD
Regorafenib—KIT—nervous system—systemic lupus erythematosus	0.00036	0.003	CbGeAlD
Regorafenib—PDGFRB—nervous system—systemic lupus erythematosus	0.000351	0.00293	CbGeAlD
Regorafenib—KIT—central nervous system—systemic lupus erythematosus	0.000346	0.00288	CbGeAlD
Regorafenib—ABCG2—nephron tubule—systemic lupus erythematosus	0.000342	0.00285	CbGeAlD
Regorafenib—PDGFRB—central nervous system—systemic lupus erythematosus	0.000338	0.00282	CbGeAlD
Regorafenib—ABL1—lung—systemic lupus erythematosus	0.000338	0.00282	CbGeAlD
Regorafenib—ABCB1—blood plasma—systemic lupus erythematosus	0.000327	0.00273	CbGeAlD
Regorafenib—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000316	0.00263	CbGeAlD
Regorafenib—ABL1—nervous system—systemic lupus erythematosus	0.000313	0.00261	CbGeAlD
Regorafenib—CYP2C8—kidney—systemic lupus erythematosus	0.000309	0.00258	CbGeAlD
Regorafenib—ABL1—central nervous system—systemic lupus erythematosus	0.000301	0.00251	CbGeAlD
Regorafenib—CYP2B6—skin of body—systemic lupus erythematosus	0.000294	0.00245	CbGeAlD
Regorafenib—CYP2B6—kidney—systemic lupus erythematosus	0.000278	0.00231	CbGeAlD
Regorafenib—Weight decreased—Dexamethasone—systemic lupus erythematosus	0.000241	0.00188	CcSEcCtD
Regorafenib—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.000239	0.00186	CcSEcCtD
Regorafenib—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000238	0.00199	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000237	0.00185	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000237	0.00184	CcSEcCtD
Regorafenib—Haemoglobin—Triamcinolone—systemic lupus erythematosus	0.000237	0.00184	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—systemic lupus erythematosus	0.000236	0.00184	CcSEcCtD
Regorafenib—Haemorrhage—Triamcinolone—systemic lupus erythematosus	0.000235	0.00183	CcSEcCtD
Regorafenib—ABCG2—bone marrow—systemic lupus erythematosus	0.000235	0.00196	CbGeAlD
Regorafenib—Haemorrhage—Methylprednisolone—systemic lupus erythematosus	0.000235	0.00183	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dexamethasone—systemic lupus erythematosus	0.000234	0.00182	CcSEcCtD
Regorafenib—Acute coronary syndrome—Betamethasone—systemic lupus erythematosus	0.000234	0.00182	CcSEcCtD
Regorafenib—Myocardial infarction—Dexamethasone—systemic lupus erythematosus	0.000233	0.00181	CcSEcCtD
Regorafenib—Myocardial infarction—Betamethasone—systemic lupus erythematosus	0.000233	0.00181	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000231	0.0018	CcSEcCtD
Regorafenib—Tremor—Cyclosporine—systemic lupus erythematosus	0.000229	0.00179	CcSEcCtD
Regorafenib—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000226	0.00176	CcSEcCtD
Regorafenib—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000225	0.00175	CcSEcCtD
Regorafenib—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000224	0.00174	CcSEcCtD
Regorafenib—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.000224	0.00174	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000223	0.00174	CcSEcCtD
Regorafenib—Fatigue—Leflunomide—systemic lupus erythematosus	0.000223	0.00174	CcSEcCtD
Regorafenib—Pain—Leflunomide—systemic lupus erythematosus	0.000221	0.00172	CcSEcCtD
Regorafenib—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.00172	CcSEcCtD
Regorafenib—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000219	0.00171	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.000218	0.0017	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000218	0.00169	CcSEcCtD
Regorafenib—Neutropenia—Prednisone—systemic lupus erythematosus	0.000217	0.00169	CcSEcCtD
Regorafenib—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000217	0.00169	CcSEcCtD
Regorafenib—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000217	0.00169	CcSEcCtD
Regorafenib—Haemoglobin—Betamethasone—systemic lupus erythematosus	0.000215	0.00167	CcSEcCtD
Regorafenib—Haemoglobin—Dexamethasone—systemic lupus erythematosus	0.000215	0.00167	CcSEcCtD
Regorafenib—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00166	CcSEcCtD
Regorafenib—Haemorrhage—Betamethasone—systemic lupus erythematosus	0.000214	0.00166	CcSEcCtD
Regorafenib—Haemorrhage—Dexamethasone—systemic lupus erythematosus	0.000214	0.00166	CcSEcCtD
Regorafenib—ABCG2—lung—systemic lupus erythematosus	0.000213	0.00178	CbGeAlD
Regorafenib—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000213	0.00166	CcSEcCtD
Regorafenib—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000212	0.00165	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.000212	0.00165	CcSEcCtD
Regorafenib—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000211	0.00164	CcSEcCtD
Regorafenib—Weight decreased—Prednisone—systemic lupus erythematosus	0.00021	0.00164	CcSEcCtD
Regorafenib—CYP3A4—kidney—systemic lupus erythematosus	0.00021	0.00175	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000207	0.00161	CcSEcCtD
Regorafenib—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.0016	CcSEcCtD
Regorafenib—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000205	0.00159	CcSEcCtD
Regorafenib—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000205	0.00159	CcSEcCtD
Regorafenib—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000204	0.00159	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	0.000204	0.00159	CcSEcCtD
Regorafenib—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.000204	0.00159	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisone—systemic lupus erythematosus	0.000203	0.00158	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	0.000202	0.00157	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000202	0.00157	CcSEcCtD
Regorafenib—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.000199	0.00155	CcSEcCtD
Regorafenib—Infection—Cyclosporine—systemic lupus erythematosus	0.000198	0.00154	CcSEcCtD
Regorafenib—CYP2B6—lung—systemic lupus erythematosus	0.000197	0.00164	CbGeAlD
Regorafenib—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000196	0.00152	CcSEcCtD
Regorafenib—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000196	0.00152	CcSEcCtD
Regorafenib—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000194	0.00151	CcSEcCtD
Regorafenib—Angiopathy—Betamethasone—systemic lupus erythematosus	0.000194	0.00151	CcSEcCtD
Regorafenib—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.000194	0.00151	CcSEcCtD
Regorafenib—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000194	0.00151	CcSEcCtD
Regorafenib—Hypertension—Prednisolone—systemic lupus erythematosus	0.000192	0.0015	CcSEcCtD
Regorafenib—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000191	0.00149	CcSEcCtD
Regorafenib—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000191	0.00149	CcSEcCtD
Regorafenib—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.00147	CcSEcCtD
Regorafenib—Alopecia—Dexamethasone—systemic lupus erythematosus	0.000189	0.00147	CcSEcCtD
Regorafenib—Alopecia—Betamethasone—systemic lupus erythematosus	0.000189	0.00147	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000188	0.00146	CcSEcCtD
Regorafenib—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000188	0.00146	CcSEcCtD
Regorafenib—Haemoglobin—Prednisone—systemic lupus erythematosus	0.000187	0.00145	CcSEcCtD
Regorafenib—Haemorrhage—Prednisone—systemic lupus erythematosus	0.000186	0.00145	CcSEcCtD
Regorafenib—Asthenia—Leflunomide—systemic lupus erythematosus	0.000186	0.00145	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000184	0.00143	CcSEcCtD
Regorafenib—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000183	0.00142	CcSEcCtD
Regorafenib—CYP2B6—nervous system—systemic lupus erythematosus	0.000182	0.00152	CbGeAlD
Regorafenib—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000182	0.00141	CcSEcCtD
Regorafenib—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000177	0.00138	CcSEcCtD
Regorafenib—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000177	0.00138	CcSEcCtD
Regorafenib—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000176	0.00137	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—systemic lupus erythematosus	0.000176	0.00137	CcSEcCtD
Regorafenib—CYP2B6—central nervous system—systemic lupus erythematosus	0.000175	0.00146	CbGeAlD
Regorafenib—Vomiting—Azathioprine—systemic lupus erythematosus	0.000174	0.00136	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000174	0.00136	CcSEcCtD
Regorafenib—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000174	0.00135	CcSEcCtD
Regorafenib—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000173	0.00135	CcSEcCtD
Regorafenib—Infestation—Methotrexate—systemic lupus erythematosus	0.000173	0.00135	CcSEcCtD
Regorafenib—Rash—Azathioprine—systemic lupus erythematosus	0.000173	0.00135	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000173	0.00135	CcSEcCtD
Regorafenib—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000173	0.00134	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000172	0.00134	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000172	0.00134	CcSEcCtD
Regorafenib—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000172	0.00134	CcSEcCtD
Regorafenib—Headache—Azathioprine—systemic lupus erythematosus	0.000172	0.00134	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	0.000172	0.00134	CcSEcCtD
Regorafenib—Pain—Cyclosporine—systemic lupus erythematosus	0.000171	0.00133	CcSEcCtD
Regorafenib—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000171	0.00133	CcSEcCtD
Regorafenib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000169	0.00132	CcSEcCtD
Regorafenib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000169	0.00141	CbGeAlD
Regorafenib—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000169	0.00131	CcSEcCtD
Regorafenib—Angiopathy—Prednisone—systemic lupus erythematosus	0.000169	0.00131	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000168	0.00131	CcSEcCtD
Regorafenib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.0013	CcSEcCtD
Regorafenib—Infection—Triamcinolone—systemic lupus erythematosus	0.000166	0.00129	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—systemic lupus erythematosus	0.000166	0.00129	CcSEcCtD
Regorafenib—Vomiting—Leflunomide—systemic lupus erythematosus	0.000165	0.00128	CcSEcCtD
Regorafenib—Alopecia—Prednisone—systemic lupus erythematosus	0.000164	0.00128	CcSEcCtD
Regorafenib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000164	0.00127	CcSEcCtD
Regorafenib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000164	0.00127	CcSEcCtD
Regorafenib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000163	0.00127	CcSEcCtD
Regorafenib—Rash—Leflunomide—systemic lupus erythematosus	0.000163	0.00127	CcSEcCtD
Regorafenib—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000163	0.00127	CcSEcCtD
Regorafenib—Nausea—Azathioprine—systemic lupus erythematosus	0.000163	0.00127	CcSEcCtD
Regorafenib—Headache—Leflunomide—systemic lupus erythematosus	0.000162	0.00126	CcSEcCtD
Regorafenib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000162	0.00126	CcSEcCtD
Regorafenib—Malnutrition—Prednisone—systemic lupus erythematosus	0.000162	0.00126	CcSEcCtD
Regorafenib—Hypertension—Betamethasone—systemic lupus erythematosus	0.00016	0.00125	CcSEcCtD
Regorafenib—Hypertension—Dexamethasone—systemic lupus erythematosus	0.00016	0.00125	CcSEcCtD
Regorafenib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000159	0.00124	CcSEcCtD
Regorafenib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000158	0.00123	CcSEcCtD
Regorafenib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000158	0.00123	CcSEcCtD
Regorafenib—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000156	0.00122	CcSEcCtD
Regorafenib—Pain—Prednisolone—systemic lupus erythematosus	0.000155	0.00121	CcSEcCtD
Regorafenib—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000155	0.00121	CcSEcCtD
Regorafenib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000154	0.0012	CcSEcCtD
Regorafenib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000154	0.0012	CcSEcCtD
Regorafenib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000154	0.0012	CcSEcCtD
Regorafenib—Nausea—Leflunomide—systemic lupus erythematosus	0.000154	0.0012	CcSEcCtD
Regorafenib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000153	0.00119	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000153	0.00119	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000153	0.00119	CcSEcCtD
Regorafenib—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000152	0.00119	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—systemic lupus erythematosus	0.000152	0.00118	CcSEcCtD
Regorafenib—Infection—Betamethasone—systemic lupus erythematosus	0.000151	0.00117	CcSEcCtD
Regorafenib—Infection—Dexamethasone—systemic lupus erythematosus	0.000151	0.00117	CcSEcCtD
Regorafenib—Anaemia—Prednisone—systemic lupus erythematosus	0.00015	0.00116	CcSEcCtD
Regorafenib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000149	0.00116	CcSEcCtD
Regorafenib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000149	0.00116	CcSEcCtD
Regorafenib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000149	0.00116	CcSEcCtD
Regorafenib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000149	0.00116	CcSEcCtD
Regorafenib—ABCB1—kidney—systemic lupus erythematosus	0.000148	0.00124	CbGeAlD
Regorafenib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000147	0.00114	CcSEcCtD
Regorafenib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000145	0.00113	CcSEcCtD
Regorafenib—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000144	0.0012	CbGeAlD
Regorafenib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000144	0.00112	CcSEcCtD
Regorafenib—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000144	0.00112	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000144	0.00112	CcSEcCtD
Regorafenib—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000143	0.00112	CcSEcCtD
Regorafenib—Pain—Triamcinolone—systemic lupus erythematosus	0.000143	0.00111	CcSEcCtD
Regorafenib—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000141	0.0011	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00014	0.00109	CcSEcCtD
Regorafenib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00014	0.00109	CcSEcCtD
Regorafenib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.00014	0.00109	CcSEcCtD
Regorafenib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00109	CcSEcCtD
Regorafenib—Hypertension—Prednisone—systemic lupus erythematosus	0.00014	0.00109	CcSEcCtD
Regorafenib—CYP3A4—nervous system—systemic lupus erythematosus	0.000138	0.00115	CbGeAlD
Regorafenib—Alopecia—Methotrexate—systemic lupus erythematosus	0.000137	0.00107	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000137	0.00107	CcSEcCtD
Regorafenib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000137	0.00106	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000136	0.00106	CcSEcCtD
Regorafenib—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000135	0.00105	CcSEcCtD
Regorafenib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00104	CcSEcCtD
Regorafenib—CYP3A4—central nervous system—systemic lupus erythematosus	0.000132	0.0011	CbGeAlD
Regorafenib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000132	0.00103	CcSEcCtD
Regorafenib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000132	0.00103	CcSEcCtD
Regorafenib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000132	0.00103	CcSEcCtD
Regorafenib—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000132	0.00103	CcSEcCtD
Regorafenib—Infection—Prednisone—systemic lupus erythematosus	0.000131	0.00102	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000131	0.00102	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000131	0.00102	CcSEcCtD
Regorafenib—Fatigue—Betamethasone—systemic lupus erythematosus	0.000131	0.00102	CcSEcCtD
Regorafenib—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000131	0.00102	CcSEcCtD
Regorafenib—Pain—Dexamethasone—systemic lupus erythematosus	0.00013	0.00101	CcSEcCtD
Regorafenib—Pain—Betamethasone—systemic lupus erythematosus	0.00013	0.00101	CcSEcCtD
Regorafenib—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.00013	0.00101	CcSEcCtD
Regorafenib—Skin disorder—Prednisone—systemic lupus erythematosus	0.000128	0.000999	CcSEcCtD
Regorafenib—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000127	0.00106	CbGeAlD
Regorafenib—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000127	0.000992	CcSEcCtD
Regorafenib—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000127	0.000989	CcSEcCtD
Regorafenib—Rash—Cyclosporine—systemic lupus erythematosus	0.000126	0.00098	CcSEcCtD
Regorafenib—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000126	0.00098	CcSEcCtD
Regorafenib—Headache—Cyclosporine—systemic lupus erythematosus	0.000125	0.000974	CcSEcCtD
Regorafenib—Anaemia—Methotrexate—systemic lupus erythematosus	0.000125	0.000973	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000124	0.000965	CcSEcCtD
Regorafenib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000124	0.000965	CcSEcCtD
Regorafenib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.000964	CcSEcCtD
Regorafenib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000956	CcSEcCtD
Regorafenib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000956	CcSEcCtD
Regorafenib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.00095	CcSEcCtD
Regorafenib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000121	0.000946	CcSEcCtD
Regorafenib—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000121	0.000942	CcSEcCtD
Regorafenib—Asthenia—Triamcinolone—systemic lupus erythematosus	0.00012	0.000934	CcSEcCtD
Regorafenib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.00012	0.000933	CcSEcCtD
Regorafenib—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.00012	0.000933	CcSEcCtD
Regorafenib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.00012	0.000933	CcSEcCtD
Regorafenib—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.00012	0.000933	CcSEcCtD
Regorafenib—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000932	CcSEcCtD
Regorafenib—Nausea—Cyclosporine—systemic lupus erythematosus	0.000119	0.000924	CcSEcCtD
Regorafenib—ABCB1—bone marrow—systemic lupus erythematosus	0.000116	0.000967	CbGeAlD
Regorafenib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000116	0.000901	CcSEcCtD
Regorafenib—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000115	0.000894	CcSEcCtD
Regorafenib—Rash—Prednisolone—systemic lupus erythematosus	0.000115	0.000892	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000115	0.000891	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000114	0.00089	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000114	0.000888	CcSEcCtD
Regorafenib—Fatigue—Prednisone—systemic lupus erythematosus	0.000114	0.000886	CcSEcCtD
Regorafenib—Headache—Prednisolone—systemic lupus erythematosus	0.000114	0.000886	CcSEcCtD
Regorafenib—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000113	0.000879	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000871	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000871	CcSEcCtD
Regorafenib—Headache—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000866	CcSEcCtD
Regorafenib—Infection—Methotrexate—systemic lupus erythematosus	0.00011	0.000854	CcSEcCtD
Regorafenib—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000109	0.000847	CcSEcCtD
Regorafenib—Asthenia—Betamethasone—systemic lupus erythematosus	0.000109	0.000847	CcSEcCtD
Regorafenib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000108	0.000843	CcSEcCtD
Regorafenib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000108	0.000841	CcSEcCtD
Regorafenib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000108	0.000841	CcSEcCtD
Regorafenib—Nausea—Prednisolone—systemic lupus erythematosus	0.000108	0.00084	CcSEcCtD
Regorafenib—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000107	0.000835	CcSEcCtD
Regorafenib—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000106	0.000827	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000106	0.000826	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000105	0.000821	CcSEcCtD
Regorafenib—Rash—Triamcinolone—systemic lupus erythematosus	0.000105	0.00082	CcSEcCtD
Regorafenib—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000105	0.00082	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000819	CcSEcCtD
Regorafenib—ABCB1—lung—systemic lupus erythematosus	0.000105	0.000876	CbGeAlD
Regorafenib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000818	CcSEcCtD
Regorafenib—Headache—Triamcinolone—systemic lupus erythematosus	0.000105	0.000815	CcSEcCtD
Regorafenib—Headache—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000813	CcSEcCtD
Regorafenib—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000104	0.000813	CcSEcCtD
Regorafenib—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000104	0.000813	CcSEcCtD
Regorafenib—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000104	0.000808	CcSEcCtD
Regorafenib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000104	0.000808	CcSEcCtD
Regorafenib—Nausea—Triamcinolone—systemic lupus erythematosus	9.93e-05	0.000773	CcSEcCtD
Regorafenib—Nausea—Methylprednisolone—systemic lupus erythematosus	9.91e-05	0.000771	CcSEcCtD
Regorafenib—ABCB1—nervous system—systemic lupus erythematosus	9.73e-05	0.000811	CbGeAlD
Regorafenib—Vomiting—Betamethasone—systemic lupus erythematosus	9.64e-05	0.000751	CcSEcCtD
Regorafenib—Vomiting—Dexamethasone—systemic lupus erythematosus	9.64e-05	0.000751	CcSEcCtD
Regorafenib—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.6e-05	0.000747	CcSEcCtD
Regorafenib—Rash—Dexamethasone—systemic lupus erythematosus	9.56e-05	0.000744	CcSEcCtD
Regorafenib—Rash—Betamethasone—systemic lupus erythematosus	9.56e-05	0.000744	CcSEcCtD
Regorafenib—Dermatitis—Betamethasone—systemic lupus erythematosus	9.56e-05	0.000744	CcSEcCtD
Regorafenib—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.56e-05	0.000744	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	9.53e-05	0.000742	CcSEcCtD
Regorafenib—Fatigue—Methotrexate—systemic lupus erythematosus	9.52e-05	0.000741	CcSEcCtD
Regorafenib—Headache—Dexamethasone—systemic lupus erythematosus	9.5e-05	0.00074	CcSEcCtD
Regorafenib—Headache—Betamethasone—systemic lupus erythematosus	9.5e-05	0.00074	CcSEcCtD
Regorafenib—Asthenia—Prednisone—systemic lupus erythematosus	9.48e-05	0.000738	CcSEcCtD
Regorafenib—Pain—Methotrexate—systemic lupus erythematosus	9.44e-05	0.000735	CcSEcCtD
Regorafenib—ABCB1—central nervous system—systemic lupus erythematosus	9.37e-05	0.000781	CbGeAlD
Regorafenib—Diarrhoea—Prednisone—systemic lupus erythematosus	9.04e-05	0.000704	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	9.03e-05	0.000703	CcSEcCtD
Regorafenib—Nausea—Dexamethasone—systemic lupus erythematosus	9.01e-05	0.000701	CcSEcCtD
Regorafenib—Nausea—Betamethasone—systemic lupus erythematosus	9.01e-05	0.000701	CcSEcCtD
Regorafenib—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.73e-05	0.000679	CcSEcCtD
Regorafenib—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.73e-05	0.000679	CcSEcCtD
Regorafenib—Vomiting—Prednisone—systemic lupus erythematosus	8.4e-05	0.000654	CcSEcCtD
Regorafenib—Rash—Prednisone—systemic lupus erythematosus	8.33e-05	0.000648	CcSEcCtD
Regorafenib—Dermatitis—Prednisone—systemic lupus erythematosus	8.32e-05	0.000648	CcSEcCtD
Regorafenib—Headache—Prednisone—systemic lupus erythematosus	8.28e-05	0.000644	CcSEcCtD
Regorafenib—Asthenia—Methotrexate—systemic lupus erythematosus	7.92e-05	0.000617	CcSEcCtD
Regorafenib—Nausea—Prednisone—systemic lupus erythematosus	7.85e-05	0.000611	CcSEcCtD
Regorafenib—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.55e-05	0.000588	CcSEcCtD
Regorafenib—Vomiting—Methotrexate—systemic lupus erythematosus	7.02e-05	0.000546	CcSEcCtD
Regorafenib—Rash—Methotrexate—systemic lupus erythematosus	6.96e-05	0.000542	CcSEcCtD
Regorafenib—Dermatitis—Methotrexate—systemic lupus erythematosus	6.95e-05	0.000541	CcSEcCtD
Regorafenib—Headache—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000538	CcSEcCtD
Regorafenib—Nausea—Methotrexate—systemic lupus erythematosus	6.56e-05	0.00051	CcSEcCtD
Regorafenib—FGFR1—Signaling Pathways—F2—systemic lupus erythematosus	5.2e-06	2.62e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—EP300—systemic lupus erythematosus	5.2e-06	2.62e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—F2—systemic lupus erythematosus	5.19e-06	2.62e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—systemic lupus erythematosus	5.16e-06	2.6e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.15e-06	2.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—JAK1—systemic lupus erythematosus	5.12e-06	2.59e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—EP300—systemic lupus erythematosus	5.12e-06	2.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CDKN1B—systemic lupus erythematosus	5.11e-06	2.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CDKN1A—systemic lupus erythematosus	5.11e-06	2.58e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CDKN1B—systemic lupus erythematosus	5.1e-06	2.57e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CDKN1A—systemic lupus erythematosus	5.1e-06	2.57e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CDKN1A—systemic lupus erythematosus	5.06e-06	2.55e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—systemic lupus erythematosus	5.04e-06	2.54e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.03e-06	2.54e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.99e-06	2.52e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CD80—systemic lupus erythematosus	4.99e-06	2.52e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CDKN1B—systemic lupus erythematosus	4.97e-06	2.51e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CD80—systemic lupus erythematosus	4.97e-06	2.51e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL2—systemic lupus erythematosus	4.97e-06	2.51e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—CDKN1A—systemic lupus erythematosus	4.97e-06	2.51e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—systemic lupus erythematosus	4.96e-06	2.5e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TYK2—systemic lupus erythematosus	4.92e-06	2.48e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—systemic lupus erythematosus	4.91e-06	2.48e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—systemic lupus erythematosus	4.88e-06	2.46e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL2—systemic lupus erythematosus	4.88e-06	2.46e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—systemic lupus erythematosus	4.88e-06	2.46e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TYK2—systemic lupus erythematosus	4.87e-06	2.46e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—systemic lupus erythematosus	4.87e-06	2.46e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.86e-06	2.45e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—EP300—systemic lupus erythematosus	4.86e-06	2.45e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR5—systemic lupus erythematosus	4.85e-06	2.45e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTGS2—systemic lupus erythematosus	4.85e-06	2.45e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—EP300—systemic lupus erythematosus	4.85e-06	2.45e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CDKN1B—systemic lupus erythematosus	4.85e-06	2.45e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NOS3—systemic lupus erythematosus	4.83e-06	2.44e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—EP300—systemic lupus erythematosus	4.81e-06	2.43e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TYK2—systemic lupus erythematosus	4.81e-06	2.43e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—systemic lupus erythematosus	4.79e-06	2.42e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.78e-06	2.41e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NOS3—systemic lupus erythematosus	4.78e-06	2.41e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.77e-06	2.41e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—systemic lupus erythematosus	4.76e-06	2.4e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.75e-06	2.4e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—systemic lupus erythematosus	4.75e-06	2.4e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—C3—systemic lupus erythematosus	4.74e-06	2.39e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—systemic lupus erythematosus	4.74e-06	2.39e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	4.73e-06	2.39e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	4.73e-06	2.39e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—EP300—systemic lupus erythematosus	4.73e-06	2.39e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS3—systemic lupus erythematosus	4.73e-06	2.38e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CDKN1A—systemic lupus erythematosus	4.72e-06	2.38e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—systemic lupus erythematosus	4.72e-06	2.38e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CDKN1A—systemic lupus erythematosus	4.7e-06	2.37e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—F2—systemic lupus erythematosus	4.67e-06	2.36e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	4.66e-06	2.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.64e-06	2.34e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL2—systemic lupus erythematosus	4.62e-06	2.33e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CDKN1B—systemic lupus erythematosus	4.59e-06	2.32e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CDKN1A—systemic lupus erythematosus	4.59e-06	2.32e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.55e-06	2.3e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EP300—systemic lupus erythematosus	4.52e-06	2.28e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFB1—systemic lupus erythematosus	4.52e-06	2.28e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.52e-06	2.28e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP9—systemic lupus erythematosus	4.5e-06	2.27e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.49e-06	2.26e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.49e-06	2.26e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—EP300—systemic lupus erythematosus	4.49e-06	2.26e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CD80—systemic lupus erythematosus	4.48e-06	2.26e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—EP300—systemic lupus erythematosus	4.48e-06	2.26e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CDKN1A—systemic lupus erythematosus	4.47e-06	2.26e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TYK2—systemic lupus erythematosus	4.44e-06	2.24e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CDKN1B—systemic lupus erythematosus	4.43e-06	2.24e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.43e-06	2.24e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.4e-06	2.22e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—systemic lupus erythematosus	4.38e-06	2.21e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—EP300—systemic lupus erythematosus	4.37e-06	2.2e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—systemic lupus erythematosus	4.35e-06	2.2e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NOS3—systemic lupus erythematosus	4.35e-06	2.2e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—systemic lupus erythematosus	4.34e-06	2.19e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—systemic lupus erythematosus	4.32e-06	2.18e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.28e-06	2.16e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EP300—systemic lupus erythematosus	4.27e-06	2.16e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EP300—systemic lupus erythematosus	4.26e-06	2.15e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	4.25e-06	2.15e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	4.25e-06	2.15e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CDKN1A—systemic lupus erythematosus	4.24e-06	2.14e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.21e-06	2.12e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—systemic lupus erythematosus	4.2e-06	2.12e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TYK2—systemic lupus erythematosus	4.2e-06	2.12e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—systemic lupus erythematosus	4.19e-06	2.11e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.18e-06	2.11e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.17e-06	2.1e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL2—systemic lupus erythematosus	4.17e-06	2.1e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—F2—systemic lupus erythematosus	4.17e-06	2.1e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.14e-06	2.09e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.13e-06	2.08e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOS3—systemic lupus erythematosus	4.12e-06	2.08e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—systemic lupus erythematosus	4.11e-06	2.07e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CDKN1B—systemic lupus erythematosus	4.09e-06	2.07e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—systemic lupus erythematosus	4.09e-06	2.07e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.09e-06	2.07e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CDKN1A—systemic lupus erythematosus	4.09e-06	2.06e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	4.07e-06	2.05e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	4.07e-06	2.05e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—systemic lupus erythematosus	4.05e-06	2.05e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.04e-06	2.04e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EP300—systemic lupus erythematosus	4.03e-06	2.03e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	4.01e-06	2.03e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CD80—systemic lupus erythematosus	3.99e-06	2.02e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	3.94e-06	1.99e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.93e-06	1.98e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.93e-06	1.98e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—systemic lupus erythematosus	3.9e-06	1.97e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EP300—systemic lupus erythematosus	3.89e-06	1.96e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—systemic lupus erythematosus	3.89e-06	1.96e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—systemic lupus erythematosus	3.87e-06	1.95e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.86e-06	1.95e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.84e-06	1.94e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—systemic lupus erythematosus	3.84e-06	1.94e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.82e-06	1.93e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TYK2—systemic lupus erythematosus	3.78e-06	1.91e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CDKN1A—systemic lupus erythematosus	3.78e-06	1.91e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.78e-06	1.91e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.77e-06	1.9e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—systemic lupus erythematosus	3.76e-06	1.9e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—systemic lupus erythematosus	3.72e-06	1.88e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	3.72e-06	1.88e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	3.72e-06	1.88e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.71e-06	1.87e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOS3—systemic lupus erythematosus	3.71e-06	1.87e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL2—systemic lupus erythematosus	3.71e-06	1.87e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—systemic lupus erythematosus	3.69e-06	1.86e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EP300—systemic lupus erythematosus	3.67e-06	1.85e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.66e-06	1.85e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EP300—systemic lupus erythematosus	3.64e-06	1.84e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	3.61e-06	1.82e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—EP300—systemic lupus erythematosus	3.59e-06	1.81e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.58e-06	1.81e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.58e-06	1.81e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.57e-06	1.8e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.56e-06	1.79e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.54e-06	1.79e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	3.52e-06	1.78e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—systemic lupus erythematosus	3.51e-06	1.77e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—systemic lupus erythematosus	3.5e-06	1.77e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—systemic lupus erythematosus	3.49e-06	1.76e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—systemic lupus erythematosus	3.49e-06	1.76e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.48e-06	1.76e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.48e-06	1.76e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	3.45e-06	1.74e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.45e-06	1.74e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.44e-06	1.73e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—systemic lupus erythematosus	3.42e-06	1.72e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—systemic lupus erythematosus	3.4e-06	1.72e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EP300—systemic lupus erythematosus	3.37e-06	1.7e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.37e-06	1.7e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—systemic lupus erythematosus	3.35e-06	1.69e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.31e-06	1.67e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EP300—systemic lupus erythematosus	3.31e-06	1.67e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.31e-06	1.67e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—systemic lupus erythematosus	3.31e-06	1.67e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.3e-06	1.67e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.29e-06	1.66e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.27e-06	1.65e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.22e-06	1.62e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	3.21e-06	1.62e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.19e-06	1.61e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.19e-06	1.61e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—systemic lupus erythematosus	3.18e-06	1.61e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—systemic lupus erythematosus	3.18e-06	1.6e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.16e-06	1.6e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.16e-06	1.59e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—systemic lupus erythematosus	3.15e-06	1.59e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—systemic lupus erythematosus	3.15e-06	1.59e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EP300—systemic lupus erythematosus	3.14e-06	1.59e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.14e-06	1.58e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EP300—systemic lupus erythematosus	3.13e-06	1.58e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—systemic lupus erythematosus	3.12e-06	1.58e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—systemic lupus erythematosus	3.1e-06	1.56e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	3.09e-06	1.56e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	3.09e-06	1.56e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—systemic lupus erythematosus	2.98e-06	1.5e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.98e-06	1.5e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.98e-06	1.5e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.97e-06	1.5e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.97e-06	1.5e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—systemic lupus erythematosus	2.96e-06	1.49e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	2.94e-06	1.48e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—systemic lupus erythematosus	2.94e-06	1.48e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—systemic lupus erythematosus	2.93e-06	1.48e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.93e-06	1.48e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.88e-06	1.45e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.87e-06	1.45e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—systemic lupus erythematosus	2.86e-06	1.44e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EP300—systemic lupus erythematosus	2.82e-06	1.43e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—systemic lupus erythematosus	2.81e-06	1.42e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—systemic lupus erythematosus	2.8e-06	1.41e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.79e-06	1.41e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—systemic lupus erythematosus	2.79e-06	1.41e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.73e-06	1.38e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.72e-06	1.38e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.67e-06	1.35e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.65e-06	1.34e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.65e-06	1.33e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	2.65e-06	1.33e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—systemic lupus erythematosus	2.64e-06	1.33e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.63e-06	1.32e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—systemic lupus erythematosus	2.55e-06	1.29e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	2.53e-06	1.28e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EP300—systemic lupus erythematosus	2.52e-06	1.27e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.49e-06	1.26e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.45e-06	1.24e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—systemic lupus erythematosus	2.41e-06	1.21e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.38e-06	1.2e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—systemic lupus erythematosus	2.38e-06	1.2e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—systemic lupus erythematosus	2.35e-06	1.19e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	2.31e-06	1.17e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.24e-06	1.13e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.22e-06	1.12e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—systemic lupus erythematosus	2.21e-06	1.11e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.19e-06	1.1e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.17e-06	1.09e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—systemic lupus erythematosus	2.17e-06	1.09e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	2.14e-06	1.08e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.12e-06	1.07e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—systemic lupus erythematosus	2.06e-06	1.04e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—systemic lupus erythematosus	2.05e-06	1.04e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.03e-06	1.02e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2e-06	1.01e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.96e-06	9.89e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.95e-06	9.84e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	1.92e-06	9.71e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	1.91e-06	9.65e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.87e-06	9.42e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—systemic lupus erythematosus	1.85e-06	9.33e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.82e-06	9.2e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	1.75e-06	8.82e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.74e-06	8.8e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.71e-06	8.61e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—systemic lupus erythematosus	1.65e-06	8.32e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.63e-06	8.22e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.59e-06	8.05e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.45e-06	7.34e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.42e-06	7.16e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.34e-06	6.75e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.33e-06	6.69e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.2e-06	6.07e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.15e-06	5.8e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.05e-06	5.31e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	8.75e-07	4.41e-06	CbGpPWpGaD
